medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Número 608

<< Anterior Siguiente >>

Rev Med Cos Cen 2013; 70 (608)


Hipotiroidismo subclínico

Callaú BA

Idioma: Español
Referencias bibliográficas: 23
Paginas: 615-620
Archivo PDF: 170.93 Kb.


RESUMEN

Actualmente el tamizaje en busca de hipotiroidismo subclinico es muy debatido, los beneficios en su manejo farmacológico parecen ser cada vez más claros pero todavía no existe evidencia científica lo suficientemente definitiva para abalar protocolos terapéuticos, exceptuando a pacientes obstétricas, en las cuales el tratamiento es prioritario. El estudio del paciente con hipotiroidismo subclinico involucra un abordaje integral e individualizado, valorando factores de riesgo y estimando beneficios.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Baloch, Z., Carayon, P., Conte- Devolx, B., Demers, L., Feldt- Rasmussen, U., Henry, J., et Al (2003) Laboratory medicine practice guidelines. EL4 Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126.

  2. Boucai, L., Hollowell, J. & Surks, M. (2011) An approach for development of age-, gender-, and ethnicityspecific thyrotropin reference limits. Thyroid 21: 5–11.

  3. Caraccio N, Ferrannini E & Monzani F. (2002) Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebocontrolled study. J Clin Endocrinol Metab 87: 1533–1538.

  4. Dardano A, Caraccio N & Monzani F. (2006) Evaluation of endothelial function in subclinical thyroid dysfunction. Thyroid 16:200–201.

  5. Dessein P, Joffe B & Stanwix A. (2004) Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 14:443–446.

  6. Garber J, Cobin R, Gharib H, Hennessey J, Klein I, Mechanick J et Al.(2012). Clinical Practice Guidelines for Hypothyroidism in Adults. Thyroid Volume 22, Number 12, 1200-1235.

  7. Gardner, D & Shoback, D. (2012) Glándula Tiroides. En D. Cooper, Endocrinología Básica y Clínica de Greenspan (9° Ed pp 163-226). Mexico DF.

  8. Gencer B, Collet TH, Virgini V, Bauer D, Gussekloo J, Cappola AR, et Al (2012) Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from six prospective cohorts. Circulation 126:1040–1049.

  9. Hollowell J, Staehling N, Flanders W, Gunter E, Spencer C & Braverman L. (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499

  10. Huber G, Staub J, Meier C, Mitrache C, Guglielmetti M, Huber P, et Al (2002) Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87:3221–3226.

  11. Iqbal A, Jorde R & Figenschau Y. (2006) Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med 260:53–61.

  12. Kubota S, Fujiwara M, Hagiwara H, Tsujimoto N, Takata K, Kudo, T, et Al (2010) Multiple thyroid cysts may be a cause of hypothyroidism in patients with relatively high iodine intake. Thyroid 20:205–208.

  13. Melmed S, Polonsky K, Larsen P. & Kronenberg H. (2011). Hypothyroidism and Thyroiditis. En G. Brent & T. Davies, Williams Textbook of Endocrinology (12° Ed pp 406-439) Philadelphia.

  14. Miller MJ, Pan C & Barzel U. (1990) The prevalence of subclinical hypothyroidism in adults with lownormal blood thyroxine levels. NY State J Med 90:541–544.

  15. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T & Stagnaro A. ( 2011) Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 96:E920–924.

  16. Rodondi N, den Elzen W, Bauer D, Cappola A, Razvi S, Walsh JP,et Al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365– 1374

  17. Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E & Aral Y. (2004) The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 27:897–903.

  18. Stagnaro A, Roman S, Cobin R, Harazy E, Alvarez M & Davies T. (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422–1425.

  19. Surks M & Hollowell J. (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575–4582

  20. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et Al. (2003) Impaired endotheliumdependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731–3737.

  21. Teixeira P, Reuters V, Ferreira M, Almeida C, Reis F, Melo B, et Al (2008) Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res 40: 50–55

  22. Vanderpump M, Tunbridge W, French J, Appleton D, Bates D, Clark F, Grimley J, et Al (1995) The incidence of thyroid disorders in the community: a twenty-year followup of the Whickham Survey. Clin Endocrinol (Oxf ) 43:55–68.

  23. Wartofsky l & Dickey R (2005). Controversy in endocrinology: The Evidence for a Narrower Thyrotropin Reference Range Is Compelling. The Journal of Clinical Endocrinology & Metabolism 90(9):5483–5488.




2020     |     www.medigraphic.com